Search
for
Sort by
Research 301–330 of 1000+
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo
- Impact of Androgenic Alopecia on the Quality of Life in Male Subjects: Results of an Observational Study from Tertiary Care Hospital
- A retrospective analysis of clinical,dermoscopic features of male patients with androgenic alopecia before and after treatment
- Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
- Androgenic Alopecia, Male and Female Pattern, Platelet Rich Plasma, Hair Pull Test.
- HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia
- The relationship between self‐esteem and hair transplantation satisfaction in male androgenetic alopecia patients
- Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia
- In silico analysis of gene expression data from bald frontal and haired occipital scalp to identify candidate genes in male androgenetic alopecia
- Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study
- Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
- Hair Are the Rankings—5-α Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia
- 15640 Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive unicenter study
- Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
- Safety and biopsy outcomes of a topical treatment (SM04554) for male androgenetic alopecia (AGA): Results from a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial
- Acceleration of Hair Growth Rate by Topical Liposomal Cepharanthine in Male Androgenetic Alopecia
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Scalp microinfusion with dutasteride using the MMP® technique for male androgenetic alopecia: a 12-month real-world observational case series
- Efficacy and safety of oral minoxidil 5 mg in male patients with androgenetic alopecia.
- Comparative Effect of Conventional and Non-Conventional Over-the-Counter Treatments for Male Androgenetic Alopecia: A Network Meta-Analysis Study
- Oral minoxidil 2.5 mg versus 5 mg for treatment of male androgenetic alopecia: a double-blind randomized clinical trial
- The efficacy of topical cetirizine using microneedling in androgenetic alopecia male patients
- The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double‐blind randomized clinical trial
- Assessment of the therapeutic efficacy of botulinum toxin in male androgenetic alopecia